mRNA vaccines are vaccine platforms that deliver messenger RNA molecules encoding target antigens into cells, prompting those cells to produce the antigen and trigger an immune response without introducing live or inactivated pathogens. Since their breakthrough authorization for COVID-19 prevention in 2020, mRNA technology has expanded rapidly into oncology, where therapeutic cancer vaccines are now advancing through clinical trials for melanoma, pancreatic cancer, and other malignancies.
Understanding the advantages and …